Adverse Drug Events (ADE)
Drug overdose deaths have dropped by 10% this year compared to last, according to data from the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received botulinum toxin injections that were counterfeit or administered in non-healthcare settings or by unlicensed or untrained individuals.
The Food and Drug Administration recently announced that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label.
As the organizations representing more than 5,000 hospitals and health systems across the country, we respectfully urge you to delay the effective date of October 9, 2014 for provisions in the final rule on Disposal of Controlled Substances that would adversely affect hospitals.
AHA Comments on USP Proposed General Chapter <800> Hazardous Drugs - Handling in Healthcare Settings
The AHA urges USP to revise its proposals to allow for alternative approaches that keep health care personnel safe and minimize the need to make major renovations to the health care facility.